ANDA 208438, held by Pharmtak Inc. Aripiprazole.
As of Nov 16, 2026, ANDA 208438 (Aripiprazole), held by Pharmtak Inc, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 26, 2018 | Original application | Tentative approval | None posted |
| Aripiprazole10MG · tablet, orally disintegrating;oral | Aripiprazole | None (tentative approval) |
| Aripiprazole15MG · tablet, orally disintegrating;oral | Aripiprazole | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters